can mochi still sell tirzepatide Health GLP-1 Medications for Weight Loss Review Mochi Health weight loss review

Tirzepatide (Mounjaro) is a dual GIP/GLP-1 receptor agonist approved by the FDA for type 2 diabetes, offering substantial HbA1c reductions of 1.9% to 2.6%

The medication, including tirzepatide injections, is delivered directly to your doorstep, along with ongoing provider support

Efficacy and Safety of Glucagon-Like Peptide-1/Glucagon Receptor Co-Agonist JNJ-64565111 in Individuals With Obesity Without Type 2 Diabetes Mellitus: A Randomized Dose-Ranging Study

Based on data submitted by the manufacturers of Mounjaro, its expiration date is 24 months from the date of manufacture when stored at 2C to 8C (in a fridge)